SAB Biotherapeutics (SABS) FCF Margin (2021 - 2024)
SAB Biotherapeutics' FCF Margin was -8358.96% in Q4 2024, down 3928.11 percentage points from -4430.85% a year earlier.
Powered by 
Analysis
SAB Biotherapeutics (SABS) FCF Margin (2021 - 2024) Analysis & Trends
For FY2024, FCF Margin at SAB Biotherapeutics came in at -2618.65%, down 1487.94 percentage points from FY2023.
- FCF Margin has now declined for four consecutive years, with a four-year change of -2613.71 percentage points (FY2020 to FY2024).
- In earlier years, FCF Margin was -1130.71% in FY2023 (-1023.51 pp), -107.20% in FY2022 (-92.49 pp), -14.71% in FY2021 (-9.78 pp) and -4.94% in FY2020.
- The Q4 2024 figure marks the lowest quarterly FCF Margin in data going back to Q1 2021.
- Compared with a year earlier, FCF Margin was higher in 1 of the last seven quarters, with an average year-over-year change of -1772.28 percentage points.
- The best year-over-year quarter for FCF Margin over five years was Q2 2024 (a gain of 2802.38 percentage points); the worst was Q2 2023 (a drop of 5675.63 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.01% |
| 10 | SAB Biotherapeutics | 223.71 Mn | -193.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -8,358.96% |
| Jun 30, 2024 | -2,952.95% |
| Mar 31, 2024 | -1,151.74% |
| Dec 31, 2023 | -4,430.85% |
| Sep 30, 2023 | -414.49% |
| Jun 30, 2023 | -5,755.33% |
| Mar 31, 2023 | -279.99% |
| Dec 31, 2022 | -77.41% |
| Sep 30, 2022 | -222.78% |
| Jun 30, 2022 | -79.69% |
| Mar 31, 2022 | -92.31% |
| Dec 31, 2021 | -65.47% |
| Sep 30, 2021 | 3.88% |
| Jun 30, 2021 | -54.09% |
| Mar 31, 2021 | 44.68% |
API Access
SAB Biotherapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();